Roberts, K. G., Pei, D., Campana, D., Payne-Turner, D., Li, Y., Cheng, C., . . . Pui, C. (2014). Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. Journal of clinical oncology, 32(27), 3012. https://doi.org/10.1200/JCO.2014.55.4105
Chicago Style (17th ed.) CitationRoberts, Kathryn G., et al. "Outcomes of Children with BCR-ABL1–like Acute Lymphoblastic Leukemia Treated with Risk-directed Therapy Based on the Levels of Minimal Residual Disease." Journal of Clinical Oncology 32, no. 27 (2014): 3012. https://doi.org/10.1200/JCO.2014.55.4105.
MLA (9th ed.) CitationRoberts, Kathryn G., et al. "Outcomes of Children with BCR-ABL1–like Acute Lymphoblastic Leukemia Treated with Risk-directed Therapy Based on the Levels of Minimal Residual Disease." Journal of Clinical Oncology, vol. 32, no. 27, 2014, p. 3012, https://doi.org/10.1200/JCO.2014.55.4105.